Invasight raised CHF 4.5 million in a round led by Occident.
05 June 2022
05 June 2022
Total investments received (USD): 4.67m
Round value (USD): 4.67m
Company: Invasight
Industry:
Biotech
Health services
Related deals
Nanolive to extend series C with $2.2 million
Investments
20 September 2022
AC BioScience secured CHF 2.5 million
Investments
21 August 2022
Navignostics raised CHF 1 million
Investments
21 August 2022
Bionter raised $3M in a seed funding round led by Dynamk Capital.
Investments
04 April 2022
Adiposs raises CHF1.8M with Privilège Ventures, Kingbridge, FONGIT, CR Ventures
Investments
05 December 2021
Belgium
Netherlands
Austria
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden
France
Ireland
Italy
Portugal
Spain
United Kingdom